These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5885863)

  • 1. Availability of platelet Factor 3 and activation of factor XII in thrombasthenia.
    Castaldi PA; Larrieu MJ; Caen J
    Nature; 1965 Jul; 207(995):422-4. PubMed ID: 5885863
    [No Abstract]   [Full Text] [Related]  

  • 2. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.
    HARDISTY RM; HUTTON RA
    Br J Haematol; 1965 May; 11():258-68. PubMed ID: 14282063
    [No Abstract]   [Full Text] [Related]  

  • 3. THROMBASTHENIA. STUDIES ON THREE CASES.
    HARDISTY RM; DORMANDY KM; HUTTON RA
    Br J Haematol; 1964 Jul; 10():371-87. PubMed ID: 14179492
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII.
    Walsh PN
    Br J Haematol; 1972 Apr; 22(4):393-405. PubMed ID: 5028124
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet coagulant activities in thrombasthenia.
    Walsh PN
    Br J Haematol; 1972 Nov; 23(5):553-69. PubMed ID: 4636188
    [No Abstract]   [Full Text] [Related]  

  • 6. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of bovine platelet cationic proteins which inhibit the surface-mediated activation of factor XII and prekallikrein.
    Kodama K; Kato H; Iwanaga S
    J Biochem; 1985 Jan; 97(1):139-51. PubMed ID: 3158644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
    HOAK JC; CONNOR WE; WARNER ED
    J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet adhesiveness in Hageman trait.
    Walsh PN
    Lancet; 1970 Sep; 2(7672):575. PubMed ID: 4195244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibilities of acting on the platelet functions in thrombasthenia or Glanzmann-Naegeli thrombopathy of vitro and in vivo].
    MARX R; APPEL W
    Hemostase; 1962 Jun; 2():133-7. PubMed ID: 13933228
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregometry in Hageman-deficients and in aspirin treated normal subjects.
    Sarji KE; Iatridis PG; Rodman NF; Ferguson JH
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):177-88. PubMed ID: 5030704
    [No Abstract]   [Full Text] [Related]  

  • 13. A new abnormality of platelet function.
    Papayannis AG; Wood JK; Israëls MC
    Acta Haematol; 1970; 44(2):98-110. PubMed ID: 4991714
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of intravascular coagulation by collagen.
    Niewiarowski S; Stuart RK; Thomas DP
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):196-200. PubMed ID: 5924426
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating anticoagulant against Factor XII and platelet antibodies in systemic lupus erythematosus.
    Gandolfo GM; Afeltra A; Amoroso A; Biancolella F; Ferri GM
    Acta Haematol; 1977; 57(3):135-42. PubMed ID: 402772
    [No Abstract]   [Full Text] [Related]  

  • 16. Importances of polar groups for initiating blood coagulation and aggregating platelets.
    Nossel HL; Wilner GD; LeRoy EC
    Nature; 1969 Jan; 221(5175):75-6. PubMed ID: 5782621
    [No Abstract]   [Full Text] [Related]  

  • 17. [PLATELET ADHESIVITY AND VISCOUS METAMORPHOSIS. STUDY IN VARIOUS HEMORRHAGIC DISEASES].
    VERRASTRO T; COELHO E; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():397-406. PubMed ID: 14116074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet membrane abnormalities in thrombasthenia and essential athrombia (author's transl)].
    Ando Y; Watanabe K; Yamamoto M; Ikeda Y; Muraki H; Kikuchi M; Matsuda S; Yamada K; Takahashi R
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):966-71. PubMed ID: 735708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of factor XII deficiency with prolonged bleeding time].
    Sroczyński J; Kossmann S; Wegiel A
    Acta Haematol Pol; 1971; 2(3):239-42. PubMed ID: 5161839
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activation mechanism of bovine factor XII on foreign surfaces--activation by polysaccharide sulfate and sulfatide and inhibition by platelet components].
    Kato H; Shimada T; Ohno Y; Sugo T; Kodama K
    Rinsho Byori; 1982 Jun; Suppl 50():102-13. PubMed ID: 6215509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.